Advanced

Arkadia regulates tumor metastasis by modulation of the TGF-β pathway

Briones-Orta, Marco A; Levy, Laurence; Madsen, Chris D LU ; Das, Debipriya; Erker, Yigit; Sahai, Erik and Hill, Caroline S (2013) In Cancer Research 73(6). p.10-1800
Abstract

TGF-β can act as a tumor suppressor at early stages of cancer progression and as a tumor promoter at later stages. The E3 ubiquitin ligase Arkadia (RNF111) is a critical component of the TGF-β signaling pathway, being required for a subset of responses, those mediated by Smad3-Smad4 complexes. It acts by mediating ligand-induced degradation of Ski and SnoN (SKIL), which are 2 potent transcriptional repressors. Here, we investigate the role of Arkadia in cancer using model systems to address both potential tumor-suppressive and tumor-promoting roles. Stable reexpression of Arkadia in lung carcinoma NCI-H460 cells, which we show contain a hemizygous nonsense mutation in the Arkadia/RNF111 gene, efficiently restored TGF-β-induced... (More)

TGF-β can act as a tumor suppressor at early stages of cancer progression and as a tumor promoter at later stages. The E3 ubiquitin ligase Arkadia (RNF111) is a critical component of the TGF-β signaling pathway, being required for a subset of responses, those mediated by Smad3-Smad4 complexes. It acts by mediating ligand-induced degradation of Ski and SnoN (SKIL), which are 2 potent transcriptional repressors. Here, we investigate the role of Arkadia in cancer using model systems to address both potential tumor-suppressive and tumor-promoting roles. Stable reexpression of Arkadia in lung carcinoma NCI-H460 cells, which we show contain a hemizygous nonsense mutation in the Arkadia/RNF111 gene, efficiently restored TGF-β-induced Smad3-dependent transcription, and substantially decreased the ability of these cells to grow in soft agar in vitro. However, it had no effect on tumor growth in vivo in mouse models. Moreover, loss of Arkadia in cancer cell lines and human tumors is rare, arguing against a prominent tumor-suppressive role. In contrast, we have uncovered a potent tumor-promoting function for Arkadia. Using 3 different cancer cell lines whose tumorigenic properties are driven by TGF-β signaling, we show that loss of Arkadia function, either by overexpression of dominant negative Arkadia or by siRNA-induced knockdown, substantially inhibited lung colonization in tail vein injection experiments in immunodeficient mice. Our findings indicate that Arkadia is not critical for regulating tumor growth per se, but is required for the early stages of cancer cell colonization at the sites of metastasis.

(Less)
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Animals, Biocatalysis, Blotting, Western, Cell Line, Tumor, Humans, Mice, Mutation, Neoplasm Metastasis, Nuclear Proteins, Smad3 Protein, Transcription, Genetic, Transforming Growth Factor beta, Ubiquitin-Protein Ligases, Journal Article, Research Support, Non-U.S. Gov't
in
Cancer Research
volume
73
issue
6
pages
11 pages
publisher
American Association for Cancer Research Inc.
external identifiers
  • scopus:84875470772
ISSN
1538-7445
DOI
10.1158/0008-5472.CAN-12-1916
language
English
LU publication?
no
id
77379e09-e245-45b2-adf7-33004276c961
date added to LUP
2016-12-06 10:16:29
date last changed
2018-01-07 11:39:12
@article{77379e09-e245-45b2-adf7-33004276c961,
  abstract     = {<p>TGF-β can act as a tumor suppressor at early stages of cancer progression and as a tumor promoter at later stages. The E3 ubiquitin ligase Arkadia (RNF111) is a critical component of the TGF-β signaling pathway, being required for a subset of responses, those mediated by Smad3-Smad4 complexes. It acts by mediating ligand-induced degradation of Ski and SnoN (SKIL), which are 2 potent transcriptional repressors. Here, we investigate the role of Arkadia in cancer using model systems to address both potential tumor-suppressive and tumor-promoting roles. Stable reexpression of Arkadia in lung carcinoma NCI-H460 cells, which we show contain a hemizygous nonsense mutation in the Arkadia/RNF111 gene, efficiently restored TGF-β-induced Smad3-dependent transcription, and substantially decreased the ability of these cells to grow in soft agar in vitro. However, it had no effect on tumor growth in vivo in mouse models. Moreover, loss of Arkadia in cancer cell lines and human tumors is rare, arguing against a prominent tumor-suppressive role. In contrast, we have uncovered a potent tumor-promoting function for Arkadia. Using 3 different cancer cell lines whose tumorigenic properties are driven by TGF-β signaling, we show that loss of Arkadia function, either by overexpression of dominant negative Arkadia or by siRNA-induced knockdown, substantially inhibited lung colonization in tail vein injection experiments in immunodeficient mice. Our findings indicate that Arkadia is not critical for regulating tumor growth per se, but is required for the early stages of cancer cell colonization at the sites of metastasis.</p>},
  author       = {Briones-Orta, Marco A and Levy, Laurence and Madsen, Chris D and Das, Debipriya and Erker, Yigit and Sahai, Erik and Hill, Caroline S},
  issn         = {1538-7445},
  keyword      = {Animals,Biocatalysis,Blotting, Western,Cell Line, Tumor,Humans,Mice,Mutation,Neoplasm Metastasis,Nuclear Proteins,Smad3 Protein,Transcription, Genetic,Transforming Growth Factor beta,Ubiquitin-Protein Ligases,Journal Article,Research Support, Non-U.S. Gov't},
  language     = {eng},
  month        = {03},
  number       = {6},
  pages        = {10--1800},
  publisher    = {American Association for Cancer Research Inc.},
  series       = {Cancer Research},
  title        = {Arkadia regulates tumor metastasis by modulation of the TGF-β pathway},
  url          = {http://dx.doi.org/10.1158/0008-5472.CAN-12-1916},
  volume       = {73},
  year         = {2013},
}